Your browser doesn't support javascript.
NOTTO COVID-19 vaccine guidelines for transplant recipients
Indian Journal of Transplantation ; 15(1):1-3, 2021.
Article in English | Scopus | ID: covidwho-1187091
ABSTRACT
In December 2019 Novel corona virus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID 19 Vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID -19 infection or atleast diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno compromised patients should not receive live vaccines as they can cause vaccine related disease and hence the guidelines suggest that all transplant recipients should receive age appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population. © 2021 Indian Journal of Transplantation ;Published by Wolters Kluwer - Medknow.

Full text: Available Collection: Databases of international organizations Database: Scopus Type of study: Clinical Practice Guide Topics: Vaccines Language: English Journal: Indian Journal of Transplantation Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Type of study: Clinical Practice Guide Topics: Vaccines Language: English Journal: Indian Journal of Transplantation Year: 2021 Document Type: Article